| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |